ClinicalTrials.gov
ClinicalTrials.gov Menu

LifeCourse: A Supportive Care Approach for Patients Late in Life

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01746446
Recruitment Status : Completed
First Posted : December 11, 2012
Last Update Posted : May 8, 2017
Sponsor:
Collaborator:
Robina Foundation
Information provided by (Responsible Party):
Allina Health System

Brief Summary:
The purpose of the study is to test a new model of care for patients with an ongoing or significant medical condition.

Condition or disease Intervention/treatment Phase
Ongoing or Significant Medical Condition Other: Care team Not Applicable

Detailed Description:
LifeCourse is a late life care approach that promotes whole person care through a structured approach built upon an expanded set of palliative care domains and chronic illness care practices. It includes a trained lay healthcare worker as the primary contact who follows the patient across care settings and over time. The care guide asks patients and caregivers to articulate individualized goals and take part in decision making, and uses a family-oriented approach to understand needs, leverage strengths, and empower families to effectively support the individual living with serious illness.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 903 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: LifeCourse: A Supportive Care Approach for Patients Late in Life
Actual Study Start Date : October 2012
Actual Primary Completion Date : March 31, 2017
Actual Study Completion Date : March 31, 2017

Arm Intervention/treatment
Experimental: Care team
Patients are offered the support and services of the care team.
Other: Care team
Provides additional support to patients, family, and friends.
No Intervention: Usual Care
Patients receive usual care.



Primary Outcome Measures :
  1. Patient goals [ Time Frame: Baseline and 2 years ]
  2. Number of patients enrolled in hospice [ Time Frame: Baseline and 2 years ]
  3. Number of inpatient hospital days [ Time Frame: Baseline and 2 years ]

Secondary Outcome Measures :
  1. Patient quality of life [ Time Frame: Date of enrollment and every 3 months for up to 26 months ]
  2. Patient experience [ Time Frame: Date of enrollment and every 3 months for up to 26 months ]
  3. Caregiver quality of life [ Time Frame: Date of enrollment and every 3 months for up to 26 months ]
  4. Caregiver experience [ Time Frame: Date of enrollment and every 3 months for up to 26 months ]
  5. Total cost of care [ Time Frame: Baseline and 2 years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion criteria

  • Patient has an Allina Health primary or specialty provider
  • Patient's medical chart indicates an on-going or significant medical condition
  • LifeCourse will invite vulnerable patients to enroll, including:
  • Critically ill patients
  • Cognitively impaired patients
  • Elderly patients, some of whom may have cognitive impairment and/or be institutionalized

Exclusion Criteria

  • Patient resides in a zip code which does not lie partially within a 45 mile radius from the Allina Health Commons in Minneapolis, Minnesota.
  • Patient has not visited an Allina facility, affiliate, or community partner within the last year.
  • Patient is eligible for hospice.
  • Patient is actively dying.
  • Patient is abusive or is discharged against medical advice (AMA).

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01746446


Locations
United States, Minnesota
Augustana Health Care Center
Minneapolis, Minnesota, United States, 55404
Abbott Northwestern Hospital
Minneapolis, Minnesota, United States, 55407
Walker Methodist Health Center
Minneapolis, Minnesota, United States, 55409
Sponsors and Collaborators
Allina Health System
Robina Foundation
Investigators
Principal Investigator: Eric W Anderson, MD Allina Health

Publications:
Responsible Party: Allina Health System
ClinicalTrials.gov Identifier: NCT01746446     History of Changes
Other Study ID Numbers: 38632
First Posted: December 11, 2012    Key Record Dates
Last Update Posted: May 8, 2017
Last Verified: May 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No